Results 21 to 30 of about 539 (158)

Augmentation of NAD+ by Dunnione Ameliorates Imiquimod-Induced Psoriasis-Like Dermatitis in Mice

Journal of Inflammation Research, 2022
Seung Hoon Lee,1,* Hyung-Jin Kim,1,* Gi-Su Oh,1 Su-Bin Lee,1 Dipendra Khadka,1 Wal Cao,1 Seong-Kyu Choe,1 Hyeok Shim,2 Chang-Deok Kim,3 Tae Hwan Kwak,4 Hong-Seob So1,4 1Department of Microbiology, Wonkwang University School of Medicine, Iksan ...
Lee SH, Kim HJ, Oh GS, Lee SB, Khadka D, Cao W, Choe SK, Shim H, Kim CD, Kwak TH, So HS   +10 more
doaj  

Psoriasis [PDF]

Cold Spring Harbor Perspectives in Medicine, 2014
Psoriasis is a common chronic inflammatory skin disease with a spectrum of clinical phenotypes and results from the interplay of genetic, environmental, and immunological factors. Four decades of clinical and basic research on psoriasis have elucidated many of the pathogenic mechanisms underlying disease and paved the way to effective targeted ...
Paola, Di Meglio, Federica, Villanova, Frank O, Nestle   +2 more
openaire   +2 more sources

Dialysis for Psoriasis [PDF]

JAMA: The Journal of the American Medical Association, 1979
To the Editor.— Buselmeier et al (240:1270, 1978) have described a psoriatic patient who responded to dialytic therapy. They concluded that "the apparent success of dialysis in treatment of intractable psoriasis... may indicate application of this mode of therapy to psoriatic patients who do not have renal failure." Since the publication of their ...
Sima Halevy, Eleasar J. Feuerman, Joseph B. Rosenfeld, Jonathan Halevy   +3 more
openaire   +7 more sources

Management Strategies for Pediatric Moderate-to-Severe Plaque Psoriasis: Spotlight on Biologics

Pediatric Health, Medicine and Therapeutics, 2023
Angelo Ruggiero,1 Antonio Portarapillo,1 Matteo Megna,1 Cataldo Patruno,2 Maddalena Napolitano1 1Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, 80131, Italy; 2Department of Health Sciences ...
Ruggiero A, Portarapillo A, Megna M, Patruno C, Napolitano M   +4 more
doaj  

Weighted Gene Co-Expression Network Analysis of Oxymatrine in Psoriasis Treatment

Journal of Inflammation Research, 2023
Xiaoxiao Xue,1 Yatao Guo,2 Qianying Zhao,3 Yongwen Li,1 Mi Rao,1 Wenjing Qi,1 Huijuan Shi1 1Department of Dermatovenereology, the General Hospital of Ningxia Medical University, Yinchuan, 750004, People’s Republic of China; 2Dermatological Department ...
Xue X, Guo Y, Zhao Q, Li Y, Rao M, Qi W, Shi H   +6 more
doaj  

Psoriasis and Genetics

Acta Dermato Venereologica, 2020
Psoriasis is a common inflammatory skin disease caused by the interplay between multiple genetic and environmental risk factors. This review summarises recent progress in elucidating the genetic basis of psoriasis, particularly through large genome-wide association studies.
Dand, Nick, Mahil, Satveer K, Capon, Francesca, Smith, Catherine H, Simpson, Michael A, Barker, Jonathan N   +5 more
openaire   +6 more sources

Diagnosis and screening of patients with generalized pustular psoriasis

Psoriasis: Targets and Therapy, 2019
Karen Ly,* Kristen M Beck*, Mary P Smith, Quinn Thibodeaux, Tina BhutaniDepartment of Dermatology, University of California, San Francisco, CA, USA*These authors contributed equally to this work Abstract: Generalized pustular psoriasis (GPP) is a rare ...
Ly K, Beck KM, Smith MP, Thibodeaux Q, Bhutani T   +4 more
doaj  

Long-Term Effectiveness and Safety of Ixekizumab for the Treatment of Moderate-to-Severe Plaque Psoriasis: A Five-Year Multicenter Retrospective Study—IL PSO (Italian Landscape Psoriasis)

Dermatology and Therapy
Introduction The introduction of biological therapies has revolutionized the treatment of moderate-to-severe plaque psoriasis. In particular, ixekizumab, an inhibitor of interleukin-17A, has shown great results in terms of efficacy and safety in both ...
Mario Valenti, Luigi Gargiulo, Luciano Ibba, Piergiorgio Malagoli, Fabrizio Amoruso, Anna Balato, Federico Bardazzi, Martina Burlando, Carlo G. Carrera, Paolo Dapavo, Valentina Dini, Francesca M. Gaiani, Giampiero Girolomoni, Claudio Guarneri, Claudia Lasagni, Francesco Loconsole, Angelo V. Marzano, Martina Maurelli, Matteo Megna, Diego Orsini, Massimo Travaglini, Antonio Costanzo, Alessandra Narcisi   +22 more
doaj   +1 more source

Comparative effectiveness of tildrakizumab 200 mg versus tildrakizumab 100 mg in psoriatic patients with high disease burden or above 90 kg of body weight: a 16-week multicenter retrospective study – IL PSO (Italian landscape psoriasis)

Journal of Dermatological Treatment
Purpose Tildrakizumab is a selective inhibitor of IL-23 approved for the treatment of moderate-to-severe plaque psoriasis in two dosages. We conducted a 16-week multicenter retrospective study to compare the effectiveness and safety of tildrakizumab 200 ...
Luigi Gargiulo, Luciano Ibba, Ruggero Cascio Ingurgio, Piergiorgio Malagoli, Fabrizio Amoruso, Anna Balato, Federico Bardazzi, Pina Brianti, Giovanna Brunasso, Martina Burlando, Anna E. Cagni, Marzia Caproni, Carlo G. Carrera, Andrea Carugno, Francesco Caudullo, Aldo Cuccia, Paolo Dapavo, Eugenia V. Di Brizzi, Valentina Dini, Francesca M. Gaiani, Paolo Gisondi, Claudio Guarneri, Claudia Lasagni, Gaetano Licata, Francesco Loconsole, Angelo V. Marzano, Matteo Megna, Santo R. Mercuri, Maria L. Musumeci, Diego Orsini, Simone Ribero, Valentina Ruffo Di Calabria, Francesca Satolli, Davide Strippoli, Massimo Travaglini, Emanuele Trovato, Marina Venturini, Leonardo Zichichi, Mario Valenti, Antonio Costanzo, Alessandra Narcisi   +40 more
doaj   +1 more source

Psoriasis [PDF]

Journal of the Royal College of Physicians of Edinburgh, 2013
Psoriasis is a chronic, immune-mediated inflammatory skin disease affecting 1.3–2.2% of the UK population.1 Most commonly, psoriasis is characterised by well-demarcated, red plaques with adherent scale with a predilection for the scalp and extensor surfaces of the limbs.
L, Burfield, A D, Burden
openaire   +2 more sources